SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rossari Biotech rises on getting nod to incorporate wholly owned subsidiary in Bangladesh

20 Oct 2022 Evaluate

Rossari Biotech is currently trading at Rs. 913.85, up by 5.35 points or 0.59% from its previous closing of Rs. 908.50 on the BSE.

The scrip opened at Rs. 910.95 and has touched a high and low of Rs. 913.05 and Rs. 904.80 respectively. So far 1448 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1479.90 on 27-Oct-2021 and a 52 week low of Rs. 795.05 on 20-Jun-2022.

Last one week high and low of the scrip stood at Rs. 928.95 and Rs. 903.40 respectively. The current market cap of the company is Rs. 5003.56 crore.

The promoters holding in the company stood at 68.56%, while Institutions and Non-Institutions held 21.53% and 9.91% respectively.

Rossari Biotech has received approval to incorporate wholly owned subsidiary in People’s Republic of Bangladesh (Bangladesh) with an estimate aggregate Capital outlay of Bangladeshi taka 300 million (around Rs 25 crore). The wholly owned subsidiary will enable the Company to expand the market for RBL products in Bangladesh. The proposed wholly owned subsidiary to be incorporated in Bangladesh, shall carry out the business of manufacturing and sale of specialty chemicals.

Rossari Biotech is one of the leading specialty chemicals manufacturing company in India.

Rossari Biotech Share Price

472.55 -7.60 (-1.58%)
05-May-2026 11:18 View Price Chart
Peers
Company Name CMP
BASF India 3623.75
Tata Chemicals 795.25
SRF 2520.15
Pidilite Inds. 1354.20
Deepak Nitrite 1740.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×